Role of macrophage polarization in multi-organ fibrosis of chronic GVHD
巨噬细胞极化在慢性 GVHD 多器官纤维化中的作用
基本信息
- 批准号:10482430
- 负责人:
- 金额:$ 54.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AllogenicAnti-Inflammatory AgentsAutoantibodiesAutoimmuneAutomobile DrivingB-LymphocytesCell MaintenanceCellsClinicalDevelopmentEmbryonic DevelopmentErinaceidaeEventFibrosisGenesHematopoietic Stem Cell TransplantationHomeostasisHumanImmuneIn VitroLeadLigandsMediatingMolecularMorbidity - disease rateMusMyeloid CellsOrganOrgan ModelOutcomePathway interactionsPatient-Focused OutcomesPatientsPhenotypePlayProductionRoleSHH geneSTAT3 geneSamplingSiteSonicationSourceSpleenSyndromeT-LymphocyteTestingTissuesUp-RegulationWorkchronic graft versus host diseaseconnective tissue growth factordesignhuman tissueimproved outcomeinnovationmacrophagemortalitymouse modelnovelnovel strategiesnovel therapeutic interventionsmoothened signaling pathwaystem cellstranscription factortranscriptometransforming growth factor beta3
项目摘要
Project Summary/Abstract
Chronic graft versus host disease (cGVHD) represents the leading cause of non-relapse mortality and
morbidity after allogeneic hematopoietic stem cell transplantation (HCT). It is typically clinically manifested as
an autoimmune-like syndrome and systemic fibrosis. Recent studies have suggested that macrophages with
an anti-inflammatory M2-phenotype are capable of promoting fibrosis in cGVHD. However, it remains largely
undefined what drives the polarization of M2 macrophages at sites of cGVHD and how M2 macrophages
promote GVHD-related fibrotic changes. The objective of this application is to understand the role of hedgehog
(Hh) signaling in the polarization of M2 macrophages and systemic fibrosis. Specifically, we will test the
hypothesis that the Hh signaling pathway is critical for M2 macrophage polarization in cGVHD target organs,
which in turn promotes fibrosis through the production of fibrogenic factors. We will employ mouse models and
human tissues to pursue four specific aims that will allow us to define the role of Hh signaling and the source of
sonic hedgehog (SHH) in promoting pro-fibrotic macrophages in cGVHD; we will delineate molecular
mechanisms and factors mediated by macrophages that lead to an ongoing pro-fibrotic state in GVHD, and
end-organ fibrosis in cGVHD. The long-term objective of this project is to define the role of Hh signaling in
cGVHD by providing a mechanistic understanding of its effects on macrophage polarization within GVHD
target organs and its contributions to immune cell dysregulations and tissue fibrosis. Our work may lead to the
development of novel therapeutic strategies for treating systemic fibrosis in cGVHD.
项目总结/摘要
慢性移植物抗宿主病(cGVHD)是非复发性死亡的主要原因,
异基因造血干细胞移植(HCT)后的发病率。其典型的临床表现为
自身免疫样综合征和系统性纤维化最近的研究表明,
抗炎M2-表型能够促进cGVHD中的纤维化。但在很大程度上,
不确定是什么驱动了M2巨噬细胞在cGVHD部位的极化,以及M2巨噬细胞如何
促进GVHD相关的纤维化变化。这个应用程序的目的是了解刺猬的作用
(Hh)M2巨噬细胞极化和系统性纤维化中的信号传导。具体来说,我们将测试
假设Hh信号通路对于cGVHD靶器官中的M2巨噬细胞极化是关键的,
其又通过产生纤维化因子而促进纤维化。我们将采用小鼠模型,
人类组织追求四个具体的目标,这将使我们能够定义Hh信号的作用和来源,
音刺猬(SHH)促进cGVHD中促纤维化巨噬细胞;我们将描述分子生物学
由巨噬细胞介导的导致GVHD中持续的促纤维化状态的机制和因子,以及
终末器官纤维化本项目的长期目标是确定Hh信号在以下方面的作用:
通过提供其对GVHD内巨噬细胞极化的作用的机制理解,
靶器官及其对免疫细胞失调和组织纤维化的作用。我们的工作可能会导致
开发用于治疗cGVHD中的系统性纤维化的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiaopei Huang其他文献
Xiaopei Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiaopei Huang', 18)}}的其他基金
Regulation of tumor-infiltrating T cells by macrophages
巨噬细胞对肿瘤浸润 T 细胞的调节
- 批准号:
10619598 - 财政年份:2021
- 资助金额:
$ 54.71万 - 项目类别:
Regulation of tumor-infiltrating T cells by macrophages
巨噬细胞对肿瘤浸润 T 细胞的调节
- 批准号:
10430278 - 财政年份:2021
- 资助金额:
$ 54.71万 - 项目类别:
Regulation of tumor-infiltrating T cells by macrophages
巨噬细胞对肿瘤浸润 T 细胞的调节
- 批准号:
10297968 - 财政年份:2021
- 资助金额:
$ 54.71万 - 项目类别:
Role of macrophage polarization in multi-organ fibrosis of chronic GVHD
巨噬细胞极化在慢性 GVHD 多器官纤维化中的作用
- 批准号:
10248556 - 财政年份:2020
- 资助金额:
$ 54.71万 - 项目类别:
Role of macrophage polarization in multi-organ fibrosis of chronic GVHD
巨噬细胞极化在慢性 GVHD 多器官纤维化中的作用
- 批准号:
10684854 - 财政年份:2020
- 资助金额:
$ 54.71万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 54.71万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 54.71万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 54.71万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 54.71万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 54.71万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 54.71万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 54.71万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 54.71万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 54.71万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 54.71万 - 项目类别: